Boone Capital Management LLC Biogen Inc. Transaction History

Boone Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $8.42 Million - $9.5 Million	33,238 Added 52.86%	96,115 $24.7 Billion
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $923,463 - $1.07 Million	3,355 Added 5.64%	62,877 $17.9 Billion
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $4.54 Million - $5.17 Million	17,679 Added 42.25%	59,522 $16.5 Billion
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $10.6 Million - $12.8 Million	41,843 New	41,843 $11.6 Billion

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Boone Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Boone Capital Management LLC with notifications on news.